Cargando…
‘Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics’
In recent times, enormous progress has been made in improving the diagnosis and therapeutic strategies for breast carcinoma, yet it remains the most prevalent cancer and second highest contributor to cancer-related deaths in women. Breast cancer (BC) affects one in eight females globally. In 2018 al...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048735/ https://www.ncbi.nlm.nih.gov/pubmed/35495618 http://dx.doi.org/10.3389/fmolb.2022.783494 |